Stocks That Hit 52-Week Lows On Tuesday
During Tuesday's session, 454 stocks hit new 52-week lows.
Stocks That Hit 52-Week Lows On Tuesday
During Tuesday's trading, 505 companies set new 52-week lows.
Recap: VistaGen Therapeutics Q3 Earnings
VistaGen Therapeutics (NASDAQ:VTGN) reported its Q3 earnings results on Thursday, February 10, 2022 at 05:00 PM.
Here's what investors need to know about the announcement.
VistaGen Therapeutics Q3 EPS $(0.05) Beats $(0.07) Estimate, Sales $357.90K Beat $250.00K Estimate
VistaGen Therapeutics (NASDAQ:VTGN) reported quarterly losses of $(0.05) per share which beat the analyst consensus estimate of $(0.07) by 28.57 percent. This is a 28.57 percent increase over losses of $(0.07) per share
Earnings Scheduled For February 10, 2022
Companies Reporting Before The Bell
• Canada Goose Hldgs (NYSE:GOOS) is projected to report quarterly earnings at $1.46 per share on revenue of $584.49 million.
VistaGen Therapeutics Inc. Expands Clinical Development of PH94B with Initiation of Phase 2A AjDA Trial
VistaGen (NASDAQ: VTGN), a biopharmaceutical company developing new generation medicines with the potential to go beyond the current standard of care for anxiety, depression, and other central nervous systems (“CNS&rd
VistaGen Therapeutics Reports New Preclinical Mechanism Of Action Data; Co Says Data Supports PH94B’s Potential Anti-Anxiety Activity Via Peripheral Nasal Neurons Without Entry Into Brain
VistaGen Therapeutics (NASDAQ:VTGN), a biopharmaceutical company developing a new generation of medicines with potential to go beyond the current standard of care for anxiety, depression and other central
12 Health Care Stocks Moving In Thursday’s After-Market Session
Gainers
MorphoSys (NASDAQ:MOR) stock moved upwards by 15.07% to $16.26 during Thursday's after-market session. The market value of their outstanding shares is at $2.2 billion.